These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 34407977)

  • 1. Pulmonary hypertension phenotypes in patients with systemic sclerosis.
    Haque A; Kiely DG; Kovacs G; Thompson AAR; Condliffe R
    Eur Respir Rev; 2021 Sep; 30(161):. PubMed ID: 34407977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary Hypertension: How to Best Treat the Different Scleroderma Phenotypes?
    Korman BD; Lachant DJ; Castelino FV
    Rheum Dis Clin North Am; 2023 May; 49(2):345-357. PubMed ID: 37028839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary hypertension in systemic sclerosis: different phenotypes.
    Launay D; Sobanski V; Hachulla E; Humbert M
    Eur Respir Rev; 2017 Sep; 26(145):. PubMed ID: 28954767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.
    Chauvelot L; Gamondes D; Berthiller J; Nieves A; Renard S; Catella-Chatron J; Ahmad K; Bertoletti L; Camara B; Gomez E; Launay D; Montani D; Mornex JF; Prévot G; Sanchez O; Schott AM; Subtil F; Traclet J; Turquier S; Zeghmar S; Habib G; Reynaud-Gaubert M; Humbert M; Cottin V
    Arthritis Rheumatol; 2021 Feb; 73(2):295-304. PubMed ID: 32892515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary hypertension in systemic sclerosis: diagnosis by systematic screening and prognosis after three years follow-up.
    Vilela VS; Dias MM; Salgado ÂA; da Silva BRA; Lopes AJ; Bessa EJC; Bruno LP; da Costa CH; Levy RA; Rufino R
    BMC Pulm Med; 2021 Jul; 21(1):251. PubMed ID: 34325685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension.
    Xanthouli P; Jordan S; Milde N; Marra A; Blank N; Egenlauf B; Gorenflo M; Harutyunova S; Lorenz HM; Nagel C; Theobald V; Lichtblau M; Berlier C; Ulrich S; Grünig E; Benjamin N; Distler O
    Ann Rheum Dis; 2020 Mar; 79(3):370-378. PubMed ID: 31818805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical phenotypes, hemodynamic characteristics and prognosis of Chinese patients with systemic sclerosis-associated precapillary pulmonary hypertension: a retrospective study.
    Yuan YP; Yuan P; Su YL; Jiang R; Zhang R; He J; Qiu HL; Luo CJ; Liu JM; Gong SG; Wang L; Zhao QH
    Clin Rheumatol; 2022 Jun; 41(6):1675-1686. PubMed ID: 35099674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): Recent and advanced data.
    Thoreau B; Mouthon L
    Autoimmun Rev; 2024 Apr; 23(4):103506. PubMed ID: 38135175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospects for improving outcomes in systemic sclerosis-related pulmonary hypertension.
    Thakkar V; Nikpour M; Stevens WM; Proudman SM
    Intern Med J; 2015 Mar; 45(3):248-54. PubMed ID: 25735576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary arterial hypertension associated with systemic sclerosis.
    Mathai SC; Hassoun PM
    Expert Rev Respir Med; 2011 Apr; 5(2):267-79. PubMed ID: 21510736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The spectrum of systemic sclerosis-associated pulmonary hypertension: Insights from the ASPIRE registry.
    Smith H; Thompson AAR; Akil M; Alabed S; Charalampopoulos A; Dwivedi K; Elliot CA; Hameed A; Haque A; Hamilton N; Hill C; Hurdman J; Kilding R; Kuet KP; Rajaram S; Rothman AMK; Swift AJ; Wild JM; Kiely DG; Condliffe R
    J Heart Lung Transplant; 2024 Oct; 43(10):1629-1639. PubMed ID: 39260921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Update on Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: a Review of the Current Literature.
    Sundaram SM; Chung L
    Curr Rheumatol Rep; 2018 Feb; 20(2):10. PubMed ID: 29488016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Systemic sclerosis associated pulmonary arterial hypertension: the pitfalls].
    Hachulla E; Launay D; Le Pavec J; Mouthon L; Guillevin L; de Groote P
    Presse Med; 2011 Apr; 40 Suppl 1():1S46-53. PubMed ID: 21536180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scleroderma lung disease.
    Le Pavec J; Launay D; Mathai SC; Hassoun PM; Humbert M
    Clin Rev Allergy Immunol; 2011 Apr; 40(2):104-16. PubMed ID: 20063208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring and Diagnostic Approaches for Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis.
    Valenzuela A; Nandagopal S; Steen VD; Chung L
    Rheum Dis Clin North Am; 2015 Aug; 41(3):489-506. PubMed ID: 26210131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis.
    Lewis C; Sanderson R; Vasilottos N; Zheutlin A; Visovatti S
    Heart Fail Clin; 2023 Jan; 19(1):45-54. PubMed ID: 36435572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary Hypertension in Scleroderma- Evaluation and Management.
    Chennakesavulu PV; Uppaluri S; Koyi J; Jhaveri S; Avanthika C; Sakhamuri LT; Ashokbhai PK; Singh P
    Dis Mon; 2023 Jul; 69(7):101468. PubMed ID: 36163292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.
    Mathai SC; Hummers LK; Champion HC; Wigley FM; Zaiman A; Hassoun PM; Girgis RE
    Arthritis Rheum; 2009 Feb; 60(2):569-77. PubMed ID: 19180517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation and management approaches for scleroderma lung disease.
    Schoenfeld SR; Castelino FV
    Ther Adv Respir Dis; 2017 Aug; 11(8):327-340. PubMed ID: 28621173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic biomarkers for survival in systemic sclerosis-associated pulmonary hypertension.
    Mismetti V; Delavenne X; Montani D; Bezzeghoud S; Delezay O; Hodin S; Launay D; Marchand-Adam S; Nunes H; Ollier E; Reynaud-Gaubert M; Pastre J; Traclet J; Quetant S; Zeghmar S; Bertoletti L; Cottin V
    Respir Res; 2023 Nov; 24(1):273. PubMed ID: 37936223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.